Skip to main content
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.150
-0.020 (-1.71%)
At close: Apr 28, 2026, 4:00 PM EDT
1.150
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:08 AM EDT

Inovio Pharmaceuticals Revenue

In the year 2025, Inovio Pharmaceuticals had annual revenue of $65.34K, down -69.99%.

Revenue (ttm)
$65.34K
Revenue Growth
-69.99%
P/S Ratio
1,442.06
Revenue / Employee
$583
Employees
112
Market Cap
94.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202565.34K-152.41K-69.99%
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coya Therapeutics 7.95M
NeurAxis 3.57M
Rani Therapeutics Holdings 1.63M
NRx Pharmaceuticals 1.23M
Fractyl Health 3.00K
eXoZymes -700.00
Revenue Rankings

INO News

More News